Tacrolimus Treatment for Post-COVID-19 Interstitial Lung Disease.
Saved in:
| Title: | Tacrolimus Treatment for Post-COVID-19 Interstitial Lung Disease. |
|---|---|
| Authors: | Ohgushi M; Department of General Medicine, Hamanomachi Hospital, Japan., Ogo N; Department of Respiratory Medicine, Hamanomachi Hospital, Japan., Yanagihara T; Department of Respiratory Medicine, Hamanomachi Hospital, Japan., Harada Y; Department of General Medicine, Hamanomachi Hospital, Japan., Sumida K; Department of General Medicine, Hamanomachi Hospital, Japan., Egashira A; Department of General Medicine, Hamanomachi Hospital, Japan., Asoh T; Department of General Medicine, Hamanomachi Hospital, Japan., Maeyama T; Department of Respiratory Medicine, Hamanomachi Hospital, Japan., Yoshizawa S; Department of General Medicine, Hamanomachi Hospital, Japan. |
| Source: | Internal medicine (Tokyo, Japan) [Intern Med] 2022 Feb 15; Vol. 61 (4), pp. 585-589. Date of Electronic Publication: 2021 Dec 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7235 (Electronic) Linking ISSN: 09182918 NLM ISO Abbreviation: Intern Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
